Suppr超能文献

大肠杆菌延伸因子Tu中Arg230和Arg233的替换强烈增强了其对普尔沃霉素的抗性。

Substitution of Arg230 and Arg233 in Escherichia coli elongation factor Tu strongly enhances its pulvomycin resistance.

作者信息

Boon K, Krab I, Parmeggiani A, Bosch L, Kraal B

机构信息

Leiden Institute of Chemistry, Gorleaus Laboratories, Department of Biochemistry, The Netherlands.

出版信息

Eur J Biochem. 1995 Feb 1;227(3):816-22. doi: 10.1111/j.1432-1033.1995.tb20206.x.

Abstract

Pulvomycin is a strong inhibitor of protein synthesis, known to prevent the binding of aminoacyl-tRNA to elongation factor Tu.GTP (EF-Tu.GTP). Recently, three pulvomycin-resistant mutant strains have been isolated by targeted mutagenesis of the tufA gene resulting in EF-Tu substitutions at positions 230, 333 or 334. In order to analyze the functions of arginine residues located in domain II, with respect to pulvomycin resistance and the interaction with aminoacyl-tRNA, we have investigated the effect of the substitutions of the highly conserved residues Arg230 and Arg233 by site-directed mutagenesis. We have purified two mutants species, [R233S]EF-TuHis and [R230V, R233F]EF-TuHis, both with a C-terminal histidine extension to enable purification by Ni2+ affinity chromatography. In this study, we describe the in vitro characterization of these mutant proteins. The results show that the concomitant substitution of residues at positions 230 and 233, dramatically increases the pulvomycin resistance. Preliminary evidence is presented that protein synthesis is inhibited by an EF-Tu.GDP.pulvomycin complex rather than by EF-Tu.GTP.pulvomycin. Moreover, the mutant [R230V, R233F]EF-TuHis shows a stronger protection of the ester bond of aminoacyl-tRNA than wild-type EF-Tu.

摘要

普尔沃霉素是一种强力的蛋白质合成抑制剂,已知它能阻止氨酰 - tRNA与延伸因子Tu·GTP(EF - Tu·GTP)结合。最近,通过对tufA基因进行靶向诱变,分离出了三种对普尔沃霉素耐药的突变菌株,导致EF - Tu在第230、333或334位发生替换。为了分析位于结构域II中的精氨酸残基相对于普尔沃霉素耐药性以及与氨酰 - tRNA相互作用的功能,我们通过定点诱变研究了高度保守的残基Arg230和Arg233替换的影响。我们纯化了两种突变体,[R233S]EF - TuHis和[R230V, R233F]EF - TuHis,两者都有C端组氨酸延伸,以便通过Ni2 +亲和色谱法进行纯化。在本研究中,我们描述了这些突变蛋白的体外特性。结果表明,第230位和233位残基的同时替换显著增加了对普尔沃霉素的耐药性。初步证据表明,蛋白质合成是被EF - Tu·GDP·普尔沃霉素复合物抑制,而不是被EF - Tu·GTP·普尔沃霉素抑制。此外,突变体[R230V, R233F]EF - TuHis对氨酰 - tRNA酯键的保护作用比野生型EF - Tu更强。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验